Translate page

Children with chronic myeloid leukemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults:
a multicenter experience in Taiwan
Liu HC et al. Br J Cancer, January 2023 (epub ahead of print)

 

 

 

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
View our Privacy Policy